Standardizing the language used in reporting clinical trials through MedDRA is important for harmonization worldwide because it allows for consistent interpretation of data across all clinical trials and countries. Using a common language and terminology in MedDRA ensures that adverse events, medical conditions, and other outcomes are classified and coded in the same way. This consistency and harmonization facilitates the sharing and comparison of data from different clinical trials and populations.